Love & Happiness: composition, and why the name promises nothing

A couple sitting together and talking over coffee on a sunlit stone terrace

Love & Happiness is a named combination of oxytocin and PT-141. One component has an FDA-approved single-agent product for a specific indication in a specific population. No study of the pairing was identified, and the name describes no outcome.

Composition

  • oxytocin
  • pt-141

Overview

This is the grouping where the name does the most work and the evidence does the least. PT-141, as bremelanotide, has an FDA-approved single-agent product for acquired, generalized hypoactive sexual desire disorder in premenopausal women. That approval applies to that product, that indication, and that population. It does not extend to a compounded pairing with oxytocin, to men, or to anyone outside the studied population.

Why these are grouped

The rationale offered is that a peptide associated with social bonding research and a melanocortin agonist studied in sexual desire might address related concerns. Oxytocin's bonding literature is largely observational and experimental rather than therapeutic, and no published work tested the pairing.

What each ingredient contributes

pt-141

A melanocortin receptor agonist. As bremelanotide it has an FDA-approved single-agent product for one specific indication in premenopausal women.

oxytocin

A hormone with established obstetric medical uses and a separate research literature on social behaviour that has not translated into an approved therapy for relationship or emotional outcomes.

Combination evidence

  • No published or registered study of the oxytocin and PT-141 pairing was identified.
  • The FDA approval of a bremelanotide single-agent product does not apply to a compounded combination.
  • No evidence supports any emotional, relational, or bonding claim for this pairing.

PT-141's approved product has real trial data in a defined population with a defined indication, and the effect size in those trials is worth reading rather than assuming. Oxytocin's social behaviour research is largely experimental and has repeatedly failed to translate into therapeutic claims. Neither describes the pairing.

Preclinical rationale

  • Melanocortin receptor pathways are studied in sexual desire physiology.
  • Oxytocin signalling appears in social behaviour research, mostly in experimental and animal settings.

What is not established

  • Any effect of the pairing on desire, satisfaction, or relationships.
  • Any emotional or bonding outcome from oxytocin administration in this context.
  • Efficacy or safety of PT-141 outside its approved indication and population.
  • Safety of the pairing at any duration.

Questions to discuss with a physician

  • What is actually causing what I am describing?
  • Does the approved single-agent product apply to me, and what did its trials actually show?
  • Do my medicines or hormones explain part of this?
  • Is my blood pressure a reason for caution?
  • Would counselling or relationship support be part of the answer?

This page is educational. Nothing here can be ordered, and nothing here is a prescription or medical advice. Compounded preparations are not FDA-approved. To ask about current availability, visit goal.md/peptides/connect or call or text 314-907-3103.

Medically reviewed by Michael Fitch, MD, MD. Last reviewed 2026-08-15.